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Background: This study was to elucidate the psychometric properties of the Korean version of the Diabetes
Symptom Checklist-Revised (K-DSC-R), which is a patient-reported outcome measure of diabetes symptom burden.
Methods: A sample of 432 Korean patients with diabetes was recruited from university hospitals. The data were
analyzed using exploratory factor analysis (EFA), confirmatory factor analysis (CFA), multitrait/multi-item correlation,
Pearson’s correlation, t-test, ANOVA, and Cronbach’s alpha for construct, item-convergent/discriminant, concurrent,
and known-groups validity, and internal consistency reliability.
Results: EFA extracted a total of 29 items clustered into 7 subscales from the K-DSC-R. The construct of the
seven-subscales was supported by CFA. The scaling success rates of item-convergent validity were 100% for all subscales,
and those of item-discriminant validity ranged from 83.3% to 100%. Patients in more-depressed groups and in the
HbA1c-uncontrolled group had higher K-DSC-R scores, satisfying the known-groups validity. The subscales of the
K-DSC-R were moderately correlated with health-related quality of life, indicative of the established concurrent
validity. The Cronbach’s alpha of the K-DSC-R was 0.92.
Conclusions: The psychometric properties of the K-DSC-R have been established. It is thus appropriate for use
with respect to reliability and validity in practice and clinical trials for Korean patients with type 2 diabetes.
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Diabetes has reached epidemic levels. In 2012 about 371
million people in the world had diabetes, and this num-
ber is expected to rise to 522 million by 2030, increasing
in every country [1]. According to the Korean National
Health and Nutrition Examination Survey [2], the preva-
lence of diabetes among adults aged ≥ 30 years was 9.9%
in 2012. The reported prevalence was increased with age,
being 1.9%, 5.0%, 12.6%, 20.3%, and 22.0% among individ-
uals in their 30s, 40s, 50s, 60s, 70s and over, respectively.
Patients with type 2 diabetes experience common symp-
toms (e.g., excessive thirst, dryness of mouth, fatigue,
difficulty in thinking, and drowsiness) along with the
fluctuation of their blood glucose levels. They may also* Correspondence: ehlee@ajou.ac.kr
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reproduction in any medium, provided the orexperience other symptoms such as visual blurring,
numbness and tingling in the extremities, and calf pain
due to long-term diabetic complications [3], and may suf-
fer multiplex symptoms throughout the trajectory of the
disease process.
Symptoms are perceived subjectively in terms of what
the individual believes they mean in the physical and
psychosocial-spiritual contexts [4]. The attribute of “sub-
jective perception” implies that a symptom is better
assessed directly by the patient than, for example, by a
clinician. The assessment of patient-reported outcome
(PRO) has recently been emphasized in determining the
efficacy of new therapies. In particular, PRO measure-
ments are becoming more important in the field of
treatment effects. For example, the United States Food
and Drug Administration (2009) incorporated PRO in-
struments [e.g., measuring symptom or health-related
quality of life (HRQOL)] in the decision-making process. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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trials [5].
The Diabetes Symptom Checklist–Revised (DSC-R) is
a self-reported questionnaire measuring the occurrence
and perceived discomfort of symptoms associated with
type 2 diabetes and its potential complications. The
DSC-R comprises 34 items clustered into 8 subscales:
psychological fatigue, psychological cognitive, neuro-
pathic pain, sensory neuropathic, cardiovascular, oph-
thalmologic, hyperglycemic, and hypoglycemic subscales.
The scale measures the comprehensive symptom burden
of type 2 diabetes. The psychometric properties of the
DSC-R are empirically well established in patients with
type 2 diabetes [6].
The DSC-R has been translated into many languages,
and there are currently 47 versions (www.mapi-trust.org).
Nevertheless, the psychometric properties of the trans-
lated versions have rarely been reported. From a measure-
ment perspective, it is recommended that the psychometric
properties of an instrument that has been translated for use
in new cultures or languages should be re-evaluated in a
population that is representative of the target culture or
language [7]. Conceptually, the perception of a symptom
can be affected by an individual’s belief about illness or
ethnicity in the culture in which the individual resides [8].
Therefore, the psychometric properties of a new translated
version of the DSC-R need to be verified before it is used
in either practice or research involving a target language
or culture.
The Korean version of the DSC-R (K-DSC-R) has
already been produced, but its reliability and validity
have never been reported in Korean patients with type
2 diabetes. The purpose of the present study was thus
to elucidate the reliability and validity of the K-DSC-R
in patients with type 2 diabetes.
Methods
Study design
A cross-sectional and methodological research design
was used to evaluate the following psychometric proper-
ties of the K-DSC-R: internal consistency reliability, factor-
ial construct validity, item-convergent and discriminant
validity, concurrent validity, and known-groups validity.
Sample and data-collection procedure
A convenience sample of 432 subjects was recruited
from 2 university hospitals in South Korea, between July
and November, 2012. The number of participants met
the preferred sample size of 5–10 times per item for fac-
tor analysis [9]. Patients who were diagnosed with type 2
diabetes by physicians, aged at least 20 years, and articu-
late in the Korean language were invited to participate in
the study after receiving approval for the protocol from
the institutional review boards of the two universityhospitals (Ajou University Hospital and Chungnam Na-
tional University, College of Nursing) at which the partici-
pants were enrolled.
Potential subjects were recruited from outpatient clinics
at two university hospitals by health professionals and
briefly informed about the study. If they agreed to partici-
pate, they then met with the research assistants who in-
formed them about the purpose of this study and the
nature of their participation. Potential subjects who were
articulate and agreed to participate were asked to sign a




The DSC-R, which originated from the DSC-Type 2 that
was validated in patients with type 2 diabetes from the
Netherlands [10], comprises 34 items that are clustered
into 8 subscales. Each item asks whether or not the re-
spondent has a particular symptom in the past month. If
the respondent answers “yes”, they are asked to rate how
troublesome that particular symptom is to him/her on a
5-point Likert scale from 1 (not at all) to 5 (extremely).
The item scores are transformed from 1–5 to 0–4, with
a score of 0 also applying where a symptom does not
occur. The total and all subscale scores are summed and
divided by the total number of items in the total and
subscales. Higher scores indicate a greater symptom bur-
den. The psychometric properties of the DSC-R have been
established [6]. The Mapi Research Trust (www.mapi-trust.
org) translated the DSC-R into Korean using a translation
and back-translation technique. The K-DSC-R used in
this study was obtained from the Mapi Research Trust
after obtaining the permission of the original author of
the DSC-R questionnaire.
The Diabetes-Specific Quality of Life (D-QOL) questionnaire
The D-QOL is a self-reported questionnaire that com-
prises 16 items requiring a response on a 5-point Likert
scale, where a higher score indicates a better HRQOL.
Its content validity, factorial validity, concurrent validity,
known-groups validity, and internal consistency reliabil-
ity have been established in 402 Korean patients with
diabetes [11].
The Center for Epidemiologic Studies-Depression (CES-D)
scale
The CES-D scale is a widely-used and well-validated
measure of depression, originally developed for the general
population [12]. It comprises 20 items scored on a 4-point
scale, where scores of 0–9, 10–15, 16–24, and >24 imply
no depression, mild depression, moderate depression,
and severe depression, respectively. Internal consistency
reliability, test-retest reliability, concurrent validity, and
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in a Korean population [13].
HbA1c control status
Glycemic control was determined by HbA1c categorized
into two groups, ‘controlled’ (HbA1c <7.0% [53 mmol/mol])
and ‘uncontrolled’ (HbA1c ≥7.0% [53 mmol/mol]), based
on regular laboratory medical data obtained by high-
performance liquid chromatography [14].
Data analysis
PASW statistics software (version 18) was used to analyze
the data. Descriptive statistics were computed for the item
completeness of the K-DSC-R. The factorial validity of the
K-DSC-R scale was tested using both exploratory factor
analysis (EFA) and confirmatory factor analysis (CFA).
EFA was performed to empirically identify the structure
underlying the K-DSC-R with Korean patients with type 2
diabetes. Before conducting EFA, Bartlett’s test of spher-
icity and the Kaiser-Mayer-Olkin (KMO) measure of sam-
pling adequacy were performed to justify undertaking EFA
[15]. EFA was conducted using principal-components ana-
lysis with varimax rotation. After the rotation, factors with
an eigenvalue greater than 1 were retained. The meaning-
ful loading criterion for the factors was set at ≥0.50
[16]. Correlation coefficients among extracted factors
were computed using Pearson’s correlation to identify
the potentiality of collapsing factors due to a strong
correlation [17].
CFA was conducted to confirm whether or not the
underlying structure derived from EFA was supported.
The model parameters for CFA were estimated using
the maximum-likelihood method. The goodness-of-fit
of the model was evaluated based on the chi-square test
and the following multiple indices: ratio of chi-square value
to the degrees of freedom (CMIN/DF), root-mean-square
residual (RMR), goodness-of-fit index (GFI), root-mean-
square error of approximation (RMSEA), comparative-
fit index (CFI), and incremental-fit index (IFI). Values
of <3.0, <0.50, and <0.60 for the CMIN/DF ratio, RMR,
and RMSEA, respectively, indicate a good fit. A value
of >0.90 for GFI, CFI, and IFI served as a cutoff for an
acceptable fit [18,19].
Item-convergent and discriminant validity of the K-DSC-R
was tested using the multitrait/multi-item correlation
matrix [20]. For the correlation matrix, Pearson’s correl-
ation coefficients of an item with its own scale (cor-
rected for overlap) and other scales were computed.
Item-convergent validity is satisfied if the correlation
coefficient for an item and its own scale is ≥0.40, while
item-discriminant validity is satisfied if the correlation
coefficient between an item and its own scale is higher
(by more than two standard errors) than the correlation
coefficients between that item and the other scales.For the test of known-groups validity, it was hypothe-
sized – based on previous studies [21,22] – that the symp-
tom distress as measured using the K-DSC-R would be
higher for patients in the more-depressed groups. In
addition, it was hypothesized that there would be
greater symptom distress among patients in the HbA1c-
uncontrolled group [6]. These tests were analyzed using
t-tests or ANOVA. The effect size of known-groups validity
was assessed using Cohen’s d and squared eta value (η2).
For convergent validity it was hypothesized that K-DSC-
R scores would be at least moderately correlated with the
HRQOL score as indicated by r = 0.64-0.53 on the previ-
ous study [23]. This hypothesis was tested using Pearson’s
correlation coefficient.
Internal consistency reliability was evaluated by comput-
ing Cronbach’s alpha coefficient, with the acceptability
criterion set at ≥0.70 [24].
Results
Characteristics of the subjects
The subjects who participated in this study comprised
216 males and 216 females, aged 61.21 ± 10.66 years
(mean ± SD). Most of the patients were married (83.1%,
n = 359), approximately two-thirds (60.7%, n = 262) had
graduated from high school or above, and 40.7% (n = 176)
were employed. The duration of type 2 diabetes was
12.77 ± 8.27 years. The proportions of subjects receiving
an oral hypoglycemic agent (OHA) alone, insulin injec-
tion alone, OHA in combination with insulin injection,
and diet/exercise without medication for the treatment
for their diabetes were 62.7% (n = 271), 10.0% (n = 43),
25.0% (n = 108), and 2.3% (n = 10), respectively.
Completeness of data
The rate of missing values for each item of the K-DSC-R
was very low (0.0–0.2%). The missing values were imputed
with the mean of all non-missing values of its subscale, in
accordance with the scoring guidelines of the DSC-R.
Factorial construct validity
Bartlett’s test of sphericity was significant (χ2 = 6674.75,
p < 0.001), and the KMO index was 0.91, which indicates
that the data were suitable for EFA. Initial principal-
components analysis with varimax rotation extracted
an eight-factor solution (eigenvalue >1), which explained
62.4% of the total variance. However, five items (items 2,
5, 18, 29, and 31) did not meaningfully load onto any fac-
tors at a criterion cutoff of ≥0.50. These five items were
eliminated before conducting a subsequent principal-
components analysis, which extracted a seven-factor so-
lution that accounted for 62.68% of the total variance
(Table 1). Pearson’s correlation coefficients among the
seven factors ranged from low (r = 0.275) to moderate
(r = 0.636), implying that the subscales were related but
Table 1 Exploratory factor analysis and internal consistency reliability of the K-DSC-R
Factors and item loadings
Itema F1 F2 F3 F4 F5 F6 F7
15 Burning pain: calves 0.761 0.108 0.103 0.131 0.004 −0.124 0.176
21 Shooting pain: legs 0.747 0.200 0.068 0.095 0.180 0.096 0.068
25 Burning pain: legs 0.726 0.256 0.092 0.115 0.054 −0.038 0.139
34 Tingle/prickle: legs or feet 0.683 −0.112 0.077 0.016 0.003 0.151 0.203
11 Tingle: limbs 0.637 0.240 0.054 0.074 0.106 0.234 −0.023
26 Tingle/prickle: hands or fingers 0.581 0.046 0.104 0.007 0.085 0.280 0.077
4 Overall fatigue 0.202 0.754 0.205 0.109 0.185 0.081 0.148
1 Energy 0.130 0.725 0.154 0.142 0.112 0.077 0.202
20 Fatigue: when getting up 0.157 0.620 0.339 0.121 0.135 0.102 −0.011
6 Sleepiness 0.049 0.601 0.186 0.236 0.138 0.072 −0.073
17 Fatigue: daytime 0.190 0.536 0.222 0.177 0.273 0.206 0.086
27 Irritation 0.112 0.118 0.692 0.143 0.118 0.321 0.027
19 Irritability: before a meal 0.080 0.202 0.688 0.053 0.109 0.072 −0.011
7 Concentration 0.128 0.384 0.667 0.283 0.141 −0.073 0.148
8 Mood 0.102 0.213 0.606 0.208 0.094 0.295 0.081
33 Attention 0.114 0.199 0.599 0.232 0.105 0.048 0.257
14 Vision: getting worse 0.042 0.155 0.196 0.773 0.129 0.097 −0.034
10 Vision: blurred 0.113 0.224 0.057 0.759 0.111 0.229 0.193
28 Vision: sudden deterioration 0.111 0.159 0.292 0.730 0.039 −0.113 0.084
22 Vision: alternating clear and blurred 0.126 0.131 0.134 0.719 0.136 0.232 0.144
32 Drinking 0.056 0.121 0.058 0.073 0.801 0.046 −0.083
12 Thirsty 0.150 0.165 0.238 0.063 0.752 0.125 0.194
16 Dry mouth 0.031 0.191 0.138 0.044 0.729 0.201 0.249
23 Urination 0.105 0.138 0.054 0.182 0.689 −0.029 −0.044
13 Palpitations: heart 0.100 0.192 0.141 0.082 0.065 0.769 0.091
24 Pain: chest 0.184 0.012 0.212 0.161 0.195 0.675 0.020
30 Breath: shortness 0.232 0.401 0.096 0.178 0.191 0.508 0.240
3 Numbness: feet 0.284 0.110 0.106 0.121 0.106 0.045 0.796
9 Numbness: hands 0.259 0.117 0.138 0.155 0.050 0.154 0.718
Cronbach’s alpha 0.81 0.82 0.81 0.83 0.79 0.66 0.71
aOnly the main expression items are presented.
Values in boldface are meaningful factor loadings (≥0.50).
F1, neuropathic pain factor; F2, psychological fatigue factor; F3, hypoglycemic factor; F4, ophthalmologic factor; F5, hyperglycemic factor; F6, cardiovascular factor;
F7, sensory neuropathic factor.
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lapsed. Each factor was labeled from F1 to F7 (based on
the names of the subscales in the DSC-R) as neuropathic
pain, psychological fatigue, hypoglycemic, ophthalmologic,
hyperglycemic, cardiovascular, and sensory neuropathic
subscales, respectively.
CFA was performed with the underlying seven-factor
model. The initial model fit indices were as follows:
χ2(356) = 943.080, CMIN/DF = 2.649, RMR = 0.035, GFI =
0.868, RMSEA = 0.062, CFI = 0.888, and IFI = 0.889. These
indices implied partial failure of the acceptable criteria for
the model fit, since the values were close to their cutoffcriteria; modification indices (MIs) were therefore com-
puted. Based on the largest covariance suggested by the
MIs, two error terms were subsequently connected with
two-headed curved arrows (Figure 1). As a result, χ2(354)
was meaningfully decreased to 867.354. The modified
model fit indices were improved as follows: CMIN/DF =
2.450, RMR = 0.035, GFI = 0.877, RMSEA = 0.058, CFI =
0.902, and IFI = 0.907, indicating that the revised seven-
factor model fitted the data well overall. Figure 1 shows
the standardized loadings of this model. All values except
item 23 (which was below the criterion of 0.5) significantly
loaded onto the seven latent factors, ranging from 0.51 to
Figure 1 F1, neuropathic pain factor; F2, psychological fatigue factor; F3, hypoglycemic factor; F4, ophthalmologic factor; F5,
hyperglycemic factor; F6, cardiovascular factor; F7, sensory neuropathic factor.
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is a representative condition for diabetes [3] and was there-
fore retained.
Item-convergent and item-discriminant validity
As presented in Table 2, item-factor correlations between
items and their own factors (after correcting for overlap)
ranged from 0.501 to 0.732. Thus, all items satisfied item-
convergent validity (cutoff of 0.40), and the scaling success
rates of the item-convergent validity were all 100%. There
were several failed cases for item-discriminant validity, so
that the scaling success rates of item discrimination were
93.3% for factors 2 and 3, 83.3% for factor 6, and 100% for
factors 1, 4, 5, and 7.
Known-groups validity
The known-groups validity data are presented in Table 3.
The K-DSC-R scores differed significantly among the de-
pressed groups (F = 78.89, p < 0.001, η2 = 0.35). As hy-
pothesized, patients in the more-depressed groups had
higher K-DSC-R scores. Known-groups validity was alsotested by evaluating the HbA1c control status using the
t-test. The mean K-DSC-R score was significantly lower
in the HbA1c-controlled group (t=−2.13, p= 0.03, d= 0.65).
These findings support the known-groups validity of the
K-DSC-R.
Concurrent validity
The K-DSC-R total score was significantly and nega-
tively correlated with the overall D-QOL score (r = −0.72,
p < 0.001). The correlation coefficients between the sub-
scales of the K-DSC-R and D-QOL ranged from −0.41
to −0.62 (p < 0.001 for all). These results satisfied the
hypothesized moderate correlation between K-DSC-R
and HRQOL, supporting the concurrent validity of the
K-DSC-R.
Internal consistency of reliability
Cronbach’s alpha coefficient of the K-DSC-R was very
high, at 0.92; the coefficients of all of the subscales except
factor 6 (Cronbach’s alpha = 0.66) were above the criterion
of 0.70 (Table 1).
Table 2 Item-convergent and item-discriminant validity
Subscale
Item no. F1 F2 F3 F4 F5 F6 F7
15 0.621 0.282 0.262 0.248 0.149 0.245 0.396
21 0.652 0.381 0.314 0.266 0.317 0.424 0.374
25 0.623 0.402 0.317 0.269 0.223 0.312 0.385
34 0.545 0.167 0.179 0.142 0.114 0.254 0.351
11 0.558 0.393 0.295 0.250 0.254 0.363 0.305
26 0.503 0.279 0.250 0.187 0.201 0.330 0.331
4 0.394 0.732 0.515 0.382 0.410 0.423 0.349
1 0.333 0.635 0.463 0.388 0.345 0.394 0.319
20 0.313 0.597 0.523 0.372 0.349 0.387 0.245
6 0.208 0.495 0.430 0.373 0.309 0.306 0.174
17 0.362 0.593 0.492 0.409 0.436 0.468 0.298
27 0.281 0.438 0.614 0.378 0.306 0.440 0.268
19 0.209 0.414 0.503 0.303 0.258 0.304 0.214
7 0.305 0.609 0.687 0.496 0.366 0.347 0.324
8 0.278 0.473 0.617 0.422 0.308 0.458 0.285
33 0.289 0.467 0.580 0.415 0.290 0.350 0.340
14 0.185 0.394 0.426 0.666 0.278 0.322 0.211
10 0.304 0.445 0.435 0.689 0.307 0.418 0.382
28 0.226 0.400 0.447 0.625 0.213 0.243 0.265
22 0.287 0.402 0.445 0.645 0.302 0.405 0.307
32 0.158 0.326 0.235 0.210 0.602 0.232 0.112
12 0.318 0.438 0.435 0.311 0.680 0.407 0.305
16 0.239 0.429 0.356 0.281 0.633 0.388 0.288
23 0.184 0.336 0.260 0.260 0.501 0.193 0.163
13 0.284 0.338 0.381 0.279 0.247 0.567 0.249
24 0.309 0.290 0.364 0.295 0.235 0.443 0.227
30 0.420 0.532 0.445 0.421 0.382 0.517 0.398
3 0.432 0.317 0.332 0.296 0.254 0.328 0.556
9 0.425 0.335 0.342 0.332 0.230 0.362 0.556
Boldface values indicate meaningful item-convergent validity.
Italic values indicate failed item-discriminant validity.
Table 3 Known-groups validity: mean differences in
K-DSC-R Scores according to depression classification and
HbA1c control status
n Mean (SD) F or t (p) Post-hoc test
Depression classification
Nonea 189 1.50 (1.85)
36.79e
(p< 0.001)
a, b < c < d
(Dunnett’s T3)f
Mildb 124 2.29 (2.29)
Moderatec 79 4.00 (2.96)













eWelch’s test was computed due to the heterogeneous variance for ANOVA.
fDunnett’s T3 comparison was conducted due to the nonequal variances for
post-hoc testing.
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The present study evaluated the psychometric properties
of the K-DSC-R – which was designed to measure the
occurrence and perceived discomfort of symptoms associated
with diabetes and its potential complications – in Korean
patients with type 2 diabetes. This culturally adapted in-
strument exhibited good reliability and validity.
Different from the original 34-item DSC-R covering 8
domains, in this study the K-DSC-R comprised 7 subscales
with a total of 29 items: 6 for the neuropathic pain sub-
scale, 5 for the psychological fatigue subscale, 5 for the
hypoglycemic subscale, 4 for the ophthalmologic subscale,
4 for the hyperglycemic subscale, 3 for the cardiovascular
subscale, and 2 items for the sensory neuropathic subscale.This seven-subscale construct was well validated using
both EFA and CFA. However, there was some discrepancy
in the underlying construct between the DSC-R and K-
DSC-R (Table 4). The psychological cognitive subscale
(items 6, 7, 31, and 33) in the DSC-R was not maintained
as an independent subscale in the K-DSC-R. In this study
item 31 (“Fuzzy feeling in your head?”) was eliminated
from the statistical factor analysis, and item 6 (“Sleepiness
and drowsiness?”) was loaded onto the psychological fa-
tigue subscale of the K-DSC-R. This was congruent with a
previous study finding involving USA diabetes patients
that item 6 was loaded onto the psychological fatigue sub-
scale rather than the psychological cognitive subscale [25].
The clustering of item 6 with the psychological fatigue
subscale was not unexpected, since the psychological fa-
tigue and cognitive subscales were subdivided in the psy-
chological dimension in the original DSC-Type 2 [10].
Unlike item 6, items 7 (“Difficulty concentrating?”) and 33
(“Difficulty paying attention?”) were clustered together
with the hypoglycemic subscale in the present study. Even
though different patients can experience a range of differ-
ent symptoms when their blood glucose declines, these
two items were noted as being common symptoms of
hypoglycemia (e.g., difficulty in thinking, anger, sadness,
hunger, headache, and dizziness) [3]. It was thus reason-
able to group these items within the hypoglycemic sub-
scale in the present study. Regarding the discrepancy of
psychological cognitive subscale, a cultural difference
also needs to be considered a potentiality, since there
may exist cultural differences in cognition between
Eastern Asians (Korea, Japan, and Taiwan) and Western
people (USA) [26].
Table 4 Comparison of subscales and their items for both
the original DSC-R and the K-DSC-R
Item
no.
DSC-R subscale K-DSC-R subscale



































● Symbol showing subscales and their own items: items included in the same
subscales in both the DSC-R and K-DSC-R.
○ Symbol showing subscales and their own items: items placed in different
subscales in the K-DSC-R and the DSC-R.
PF, psychological fatigue factor; PC, psychological cognitive factor; NP,
neuropathic pain factor; NS, sensory neuropathic factor; C, cardiovascular
factor; O, ophthalmologic factor; HO, hypoglycemic factor; HE,
hyperglycemic factor.
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of six items (3, 9, 11, 26, 29, and 34). In the present study,
items 3 and 9 were retained in the sensory neuropathicsubscale (Table 4). However, items 11, 26, and 34 were
placed on the neuropathic pain subscale of the K-DSC-R,
which is perhaps not surprising from a linguistic perspec-
tive since these three items involve “tingling” or “prick-
ling” in the limbs, hands, or feet. The Korean language
contains approximately 90 vocabularies for expressing the
types and intensity of pain. “Tingle” and “prickle” (which
translate to “soo shi da” and “wook shin gau ri da,” re-
spectively, in Korean) are terms that Koreans typically use
to express “pain” [27]. It is therefore understandable that
the three items should be clustered with the neuropathic
pain subscale rather than items about numbness (loss of
sensation) in the feet or hands of the neurological sensory
subscale. This discrepancy may thus have arisen as a result
of language differences.
In the item-level tests for the item-convergent/dis-
criminant validity, the item-convergent validity of the
K-ADS-R was 100% successful, with item-subscale cor-
relation coefficients ranging from 0.443 to 0.732. This
is similar to the range of 0.44–0.78 quoted in a DSC-R
validation study [6]. However, the item-discriminant
validity test indicated that item 30 (“Shortness of
breath during physical exertion?”) was problematic. It
appears that this item is not easily distinguished from
its own cardiovascular subscale and two other sub-
scales (psychological fatigue and hypoglycemic sub-
scales). This may explained by the internal consistency
reliability. The Cronbach’s alpha values of the total and
subscales of the K-DSC-R mostly exceeded the criterion
value of 0.70; the only exception was the cardiovascular
subscale, which had a Cronbach’s alpha of 0.66. In other
words, the items in the cardiovascular subscale are not
homogeneous. A low Cronbach’s alpha (0.69) was also
found for this subscale in a psychometric study of the DSC-
R [6]. The cardiovascular subscale may therefore need to be
revised in future studies, including type 2 diabetes patients
with varying degree of cardiovascular disease.
Known-groups validity refers to the ability of an instru-
ment to discriminate among groups of people who are
known to differ according to a hypothesized indicator
[28]. As expected, the patients in the present study who
were in the more-depressed groups and in the HbA1c-
uncontrolled group had worse K-DSC-R scores. In par-
ticular, the effect size of the HbA1c control status on the
K-DSC-R mean scores was moderate to large, implying a
practical differentiation between the groups. This mean-
ingful finding can probably be explained by a poorly con-
trolled HbA1c being either directly or indirectly associated
with micro- and macrovascular diabetic complications such
as retinopathy, neuropathy, or cardiovascular problems
[29]; furthermore, these complications may be perceived as
symptomatic burdens to patients.
Concurrent validity refers to the correlation between a
studied measure with other related measures at the same
Lee et al. Health and Quality of Life Outcomes 2014, 12:77 Page 8 of 9
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and direction [30]. A previous test of concurrent validity
found that DSC-R scores were negatively correlated, with
small or moderate strength, to the HRQOL subscales
measured with a generic instrument [6]. The present study
used a diabetes-specific HRQOL instrument (D-QOL)
instead of a generic measure, so that the hypothesis of a
correlation between K-DSC-R and D-QOL scores that
was at moderate was supported, furthermore confirm-
ing the concurrent validity of the K-DSC-R.
A limitation of the present study was the lack of a re-
sponsiveness test to assess the ability to detect changes
over time when the condition of patients is known to be
altered [28]. In addition, test-retest reliability was not eval-
uated; the reliability assesses the extent to which an in-
strument yields reproducible results if it is administered
repeatedly within a certain interval to a patient whose
condition is stable throughout that interval [28]. Some of
the acute diabetes-associated symptoms of the DSC-R,
such as those associated with hyperglycemia or hypoglycemia,
can fluctuate from day to day. Therefore, the most appro-
priate time interval for the retest should be determined
before assessing the test-retest reliability of the K-DSC-R.
Conclusions
The K-DSC-R, which comprises 29 items, exhibits accept-
able factorial validity, good internal consistency reliability,
item-convergent and discriminant validity, concurrent val-
idity, and known-groups validity. It can therefore be con-
sidered reliable and valid for application in either practice
or clinical trials for Korean patients with type 2 diabetes.
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